Intestinal absorption of pallidifloside D are limited by P-glycoprotein in mice

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Xenobiotica; the fate of foreign compounds in biological systems

• Publication date

  2018-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1080/00498254.2017.1355999PMID 28707509
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The JAK2 inhibitors CEP-33779 and NVP-BSK805 have high P-gp inhibitory activity and sensitize drug-resistant cancer cells to vincristine.

  2017cited by this paper
• Tariquidar sensitizes multiple myeloma cells to proteasome inhibitors via reduction of hypoxia-induced P-gp-mediated drug resistance

  2017cited by this paper
• P-gp Protein Expression and Transport Activity in Rodent Seizure Models and Human Epilepsy.

  2017cited by this paper
• Hyperuricemia and risk of increased arterial stiffness in healthy women based on health screening in Korean population

  2017cited by this paper
• Hypouricemic effect of allopurinol are improved by Pallidifloside D based on the uric acid metabolism enzymes PRPS, HGPRT and PRPPAT.

  2016cited by this paper
• Anti-hyperuricemia effects of allopurinol are improved by Smilax riparia, a traditional Chinese herbal medicine.

  2015cited by this paper
• Pallidifloside D from Smilax riparia enhanced allopurinol effects in hyperuricemia mice.

  2015cited by this paper
• Pallidifloside D, a saponin glycoside constituent from Smilax riparia, resist to hyperuricemia based on URAT1 and GLUT9 in hyperuricemic mice.

  2014cited by this paper
• Metabolite elucidation of the Hsp90 inhibitor SNX-2112 using ultraperformance liquid chromatography/quadrupole time-of-flight mass spectrometry (UPLC-QTOF/MS)

  2014influential reference
• Effect of Ajuga bracteosa on systemic T-cell immunity in Balb/C mice: dual Th1/Th2 immunostimulatory effects.

  2014cited by this paper
• Functional ATP-Binding Cassette Drug Efflux Transporters in Isolated Human and Rat Hepatocytes Significantly Affect Assessment of Drug Disposition

  2014cited by this paper
• Study on the anti-gout activity of chlorogenic acid: improvement on hyperuricemia and gouty inflammation.

  2014cited by this paper
• Structure-activity relationships and in silico models of P-glycoprotein (ABCB1) inhibitors

  2013cited by this paper
• P-glycoprotein Inhibition for Optimal Drug Delivery

  2013cited by this paper
• Treatment of diabetes using traditional Chinese medicine: past, present and future.

  2012cited by this paper
• Trends in scientific publications of Chinese medicine.

  2012cited by this paper
• Poor oral bioavailability of a promising anticancer agent andrographolide is due to extensive metabolism and efflux by P-glycoprotein.

  2011cited by this paper
• Enhancement of Oral Bioavailability of 20(S)-Ginsenoside Rh2 through Improved Understanding of Its Absorption and Efflux Mechanisms

  2011cited by this paper
• Drug-permeability and transporter assays in Caco-2 and MDCK cell lines.

  2011cited by this paper
• Importance of P-glycoprotein for drug-drug interactions.

  2011cited by this paper
• Membrane transporters in drug development

  2010cited by this paper
• Expression and function of p-glycoprotein in normal tissues: effect on pharmacokinetics.

  2010cited by this paper
• Predicting drug-drug interactions involving the inhibition of intestinal CYP3A4 and P-glycoprotein.

  2010cited by this paper
• A prospective study of gout and cancer

  2009cited by this paper
• Disposition of naringenin via glucuronidation pathway is affected by compensating efflux transporters of hydrophilic glucuronides.

  2009cited by this paper
• Unbiased membrane permeability parameters for gabapentin using boundary layer approach

  2005cited by this paper
• Modulation of Kupffer cells on hepatic drug metabolism.

  2004cited by this paper
• SUBSTRATE DEPLETION APPROACH FOR DETERMINING IN VITRO METABOLIC CLEARANCE: TIME DEPENDENCIES IN HEPATOCYTE AND MICROSOMAL INCUBATIONS

  2004cited by this paper
• Profile of P-glycoprotein distribution in the rat and its possible influence on the salbutamol intestinal absorption process.

  2004influential reference
• In Situ Single-Pass Perfused Rat Intestinal Model for Absorption and Metabolism

  2004influential reference
• Importance of P‐glycoprotein for drug disposition in humans

  2003cited by this paper
• Metabolism of Flavonoids via Enteric Recycling: Role of Intestinal Disposition

  2003influential reference
• Endogenous drug transporters in in vitro and in vivo models for the prediction of drug disposition in man.

  2002cited by this paper
• MDCK (Madin-Darby canine kidney) cells: A tool for membrane permeability screening.

  1999cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Cyclosporine Transporter Pharmacogenomic Effect in Transplantation: An Updated Systematic Review

  2025cites this paper
• The Role of ABCB1, ABCG2, and SLC Transporters in Pharmacokinetic Parameters of Selected Drugs and Their Involvement in Drug–Drug Interactions

  2024cites this paper
• In vitro metabolism and in vivo pharmacokinetics of bentysrepinine (Y101), an investigational new drug for anti-HBV-infected hepatitis: focus on interspecies comparison

  2019cites this paper